Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 6 |
NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: A4HPV8
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.569 |
CLV_NRD_NRD_1 | 131 | 133 | PF00675 | 0.507 |
CLV_NRD_NRD_1 | 147 | 149 | PF00675 | 0.463 |
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.620 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.586 |
CLV_NRD_NRD_1 | 64 | 66 | PF00675 | 0.474 |
CLV_NRD_NRD_1 | 72 | 74 | PF00675 | 0.427 |
CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.570 |
CLV_PCSK_KEX2_1 | 122 | 124 | PF00082 | 0.418 |
CLV_PCSK_KEX2_1 | 130 | 132 | PF00082 | 0.460 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.620 |
CLV_PCSK_KEX2_1 | 45 | 47 | PF00082 | 0.586 |
CLV_PCSK_KEX2_1 | 71 | 73 | PF00082 | 0.455 |
CLV_PCSK_PC1ET2_1 | 122 | 124 | PF00082 | 0.508 |
CLV_PCSK_PC1ET2_1 | 71 | 73 | PF00082 | 0.515 |
CLV_PCSK_SKI1_1 | 132 | 136 | PF00082 | 0.394 |
DEG_APCC_DBOX_1 | 2 | 10 | PF00400 | 0.444 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.625 |
DOC_PP1_RVXF_1 | 166 | 172 | PF00149 | 0.476 |
DOC_PP1_RVXF_1 | 56 | 63 | PF00149 | 0.400 |
DOC_USP7_MATH_1 | 15 | 19 | PF00917 | 0.467 |
DOC_USP7_MATH_1 | 30 | 34 | PF00917 | 0.734 |
DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.566 |
LIG_14-3-3_CanoR_1 | 163 | 172 | PF00244 | 0.540 |
LIG_14-3-3_CanoR_1 | 46 | 54 | PF00244 | 0.579 |
LIG_BRCT_BRCA1_1 | 50 | 54 | PF00533 | 0.439 |
LIG_FHA_1 | 11 | 17 | PF00498 | 0.579 |
LIG_FHA_1 | 164 | 170 | PF00498 | 0.716 |
LIG_FHA_2 | 149 | 155 | PF00498 | 0.431 |
LIG_FHA_2 | 83 | 89 | PF00498 | 0.553 |
LIG_LIR_Apic_2 | 89 | 95 | PF02991 | 0.515 |
LIG_TRAF2_1 | 94 | 97 | PF00917 | 0.490 |
MOD_CK1_1 | 29 | 35 | PF00069 | 0.636 |
MOD_CK1_1 | 39 | 45 | PF00069 | 0.641 |
MOD_CK2_1 | 148 | 154 | PF00069 | 0.455 |
MOD_CK2_1 | 82 | 88 | PF00069 | 0.478 |
MOD_GlcNHglycan | 17 | 20 | PF01048 | 0.553 |
MOD_GlcNHglycan | 187 | 190 | PF01048 | 0.648 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.579 |
MOD_GlcNHglycan | 38 | 41 | PF01048 | 0.602 |
MOD_GlcNHglycan | 50 | 53 | PF01048 | 0.570 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.598 |
MOD_GSK3_1 | 5 | 12 | PF00069 | 0.464 |
MOD_N-GLC_1 | 36 | 41 | PF02516 | 0.498 |
MOD_NEK2_1 | 47 | 52 | PF00069 | 0.637 |
MOD_NEK2_1 | 54 | 59 | PF00069 | 0.592 |
MOD_OFUCOSY | 7 | 14 | PF10250 | 0.440 |
MOD_PKA_1 | 148 | 154 | PF00069 | 0.428 |
MOD_PKA_2 | 10 | 16 | PF00069 | 0.479 |
MOD_PKA_2 | 47 | 53 | PF00069 | 0.629 |
MOD_PKB_1 | 146 | 154 | PF00069 | 0.425 |
MOD_PKB_1 | 46 | 54 | PF00069 | 0.450 |
MOD_Plk_1 | 179 | 185 | PF00069 | 0.620 |
MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.567 |
TRG_DiLeu_BaEn_4 | 96 | 102 | PF01217 | 0.546 |
TRG_ENDOCYTIC_2 | 38 | 41 | PF00928 | 0.610 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.637 |
TRG_ER_diArg_1 | 129 | 132 | PF00400 | 0.363 |
TRG_ER_diArg_1 | 45 | 48 | PF00400 | 0.670 |
TRG_ER_diArg_1 | 72 | 75 | PF00400 | 0.404 |
TRG_Pf-PMV_PEXEL_1 | 72 | 76 | PF00026 | 0.586 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IGG6 | Leishmania donovani | 68% | 100% |
A0A3R7P526 | Trypanosoma rangeli | 48% | 100% |
A4IDM0 | Leishmania infantum | 68% | 100% |
D0A4A7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 100% |
E9ATM5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 75% | 100% |
Q4Q0X3 | Leishmania major | 67% | 97% |